Maintenance Treatment of Renal Anemia in Dialysis Subjects
Status:
Completed
Trial end date:
2019-12-24
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of molidustat in comparison
to darbepoetin alfa in dialysis subjects with renal anemia who are treated with
Erythropoiesis-Stimulating Agents (ESAs).